- Home
- PPBT vs ADIL Comparison
PPBT vs ADIL Comparison
Compare PPBT & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- ADIL
- Stock Information
- Founded
- PPBT 2010
- ADIL 2010
- Country
- PPBT Israel
- ADIL United States
- Employees
- PPBT N/A
- ADIL N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- PPBT Health Care
- ADIL Health Care
- Exchange
- PPBT Nasdaq
- ADIL Nasdaq
- Market Cap
- PPBT 6.7M
- ADIL 6.5M
- IPO Year
- PPBT N/A
- ADIL 2018
- Fundamental
- Price
- PPBT $3.61
- ADIL $1.12
- Analyst Decision
- PPBT Strong Buy
- ADIL Strong Buy
- Analyst Count
- PPBT 2
- ADIL 1
- Target Price
- PPBT $126.50
- ADIL $8.00
- AVG Volume (30 Days)
- PPBT 2.7M
- ADIL 203.6K
- Earning Date
- PPBT 11-15-2024
- ADIL 11-13-2024
- Dividend Yield
- PPBT N/A
- ADIL N/A
- EPS Growth
- PPBT N/A
- ADIL N/A
- EPS
- PPBT N/A
- ADIL N/A
- Revenue
- PPBT N/A
- ADIL N/A
- Revenue This Year
- PPBT N/A
- ADIL N/A
- Revenue Next Year
- PPBT N/A
- ADIL N/A
- P/E Ratio
- PPBT N/A
- ADIL N/A
- Revenue Growth
- PPBT N/A
- ADIL N/A
- 52 Week Low
- PPBT $2.00
- ADIL $0.77
- 52 Week High
- PPBT $20.60
- ADIL $4.17
- Technical
- Relative Strength Index (RSI)
- PPBT 47.73
- ADIL 55.23
- Support Level
- PPBT $3.56
- ADIL $1.05
- Resistance Level
- PPBT $4.22
- ADIL $1.27
- Average True Range (ATR)
- PPBT 1.42
- ADIL 0.09
- MACD
- PPBT -0.07
- ADIL -0.00
- Stochastic Oscillator
- PPBT 3.36
- ADIL 46.88
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.